ERBB2 and invasive ductal breast carcinoma: Furthermore, we analyzed the expression of E-cadherin and C/EBPβ in a series of eight invasive ductal breast carcinomas, which had been classified according to their status of estrogen receptor, progesterone receptor and HER2 (Supplementary Figure 1).